DPP9
Basic information
Region (hg38): 19:4674341-4724673
Links
Phenotypes
GenCC
Source:
- hatipoglu immunodeficiency syndrome (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Hatipoglu immunodeficiency syndrome | AR | Allergy/Immunology/Infectious | The condition can include susceptibility to infection, and antiinfectious prophylaxis and early and aggressive treatment of infections may be beneficial; HSCT has been described | Allergy/Immunology/Infectious; Craniofacial; Dermatologic; Musculoskeletal; Neurologic | 36112693 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DPP9 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 59 | 67 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 59 | 8 | 5 |
Variants in DPP9
This is a list of pathogenic ClinVar variants found in the DPP9 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-4679870-G-A | Hatipoglu immunodeficiency syndrome | Pathogenic (Apr 25, 2023) | ||
19-4679927-G-A | not specified | Uncertain significance (Feb 16, 2023) | ||
19-4682745-C-T | not specified | Uncertain significance (May 01, 2022) | ||
19-4682766-C-T | not specified | Uncertain significance (Apr 11, 2023) | ||
19-4682811-C-T | not specified | Uncertain significance (Jul 12, 2023) | ||
19-4683563-C-T | not specified | Uncertain significance (Dec 02, 2024) | ||
19-4683588-G-T | not specified | Uncertain significance (Jul 05, 2023) | ||
19-4684663-C-T | Susceptibility to severe COVID-19 | Likely pathogenic (Jul 22, 2024) | ||
19-4684719-C-T | not specified | Uncertain significance (Nov 14, 2024) | ||
19-4684722-C-T | not specified | Uncertain significance (Aug 17, 2021) | ||
19-4684770-A-G | Likely benign (Dec 31, 2019) | |||
19-4685634-C-T | not specified | Uncertain significance (Dec 18, 2023) | ||
19-4685667-T-C | not specified | Uncertain significance (Mar 25, 2024) | ||
19-4685682-C-T | not specified | Uncertain significance (May 26, 2024) | ||
19-4685712-G-A | not specified | Uncertain significance (Mar 31, 2023) | ||
19-4685724-G-A | not specified | Uncertain significance (Aug 17, 2022) | ||
19-4685765-G-A | not specified | Uncertain significance (Sep 14, 2023) | ||
19-4688787-G-T | not specified | Uncertain significance (Jun 22, 2023) | ||
19-4688808-C-T | not specified | Uncertain significance (Aug 12, 2022) | ||
19-4688812-G-T | not specified | Uncertain significance (Apr 23, 2024) | ||
19-4688818-G-T | Benign (Aug 14, 2018) | |||
19-4688838-G-A | not specified | Uncertain significance (Oct 05, 2023) | ||
19-4688841-C-T | not specified | Uncertain significance (May 20, 2024) | ||
19-4688859-C-T | not specified | Uncertain significance (Dec 27, 2023) | ||
19-4688877-C-T | not specified | Likely benign (Sep 08, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DPP9 | protein_coding | protein_coding | ENST00000262960 | 20 | 49450 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.987 | 0.0129 | 124627 | 0 | 13 | 124640 | 0.0000522 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.66 | 379 | 555 | 0.682 | 0.0000365 | 5802 |
Missense in Polyphen | 138 | 234.38 | 0.58879 | 2483 | ||
Synonymous | -0.249 | 254 | 249 | 1.02 | 0.0000191 | 1676 |
Loss of Function | 5.38 | 8 | 48.4 | 0.165 | 0.00000249 | 532 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000152 | 0.000152 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000464 | 0.0000464 |
European (Non-Finnish) | 0.0000730 | 0.0000619 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Dipeptidyl peptidase that cleaves off N-terminal dipeptides from proteins having a Pro or Ala residue at position 2.;
- Pathway
- Lung fibrosis
(Consensus)
Recessive Scores
- pRec
- 0.179
Intolerance Scores
- loftool
- 0.465
- rvis_EVS
- -0.8
- rvis_percentile_EVS
- 12.53
Haploinsufficiency Scores
- pHI
- 0.389
- hipred
- Y
- hipred_score
- 0.768
- ghis
- 0.602
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.984
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dpp9
- Phenotype
- growth/size/body region phenotype; homeostasis/metabolism phenotype; muscle phenotype; craniofacial phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); digestive/alimentary phenotype;
Gene ontology
- Biological process
- proteolysis
- Cellular component
- nucleus;cytosol
- Molecular function
- aminopeptidase activity;serine-type peptidase activity;identical protein binding